DAY-TO-DAY VARIATION IN GLYCEMIC CONTROL IN TYPE-I AND TYPE-II DIABETES-MELLITUS

被引:0
|
作者
BANTLE, JP
LAINE, DC
机构
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:147 / 149
页数:3
相关论文
共 50 条
  • [1] GLYCEMIC RESPONSE TO FAST FOODS IN TYPE-I AND TYPE-II DIABETES-MELLITUS
    GOODMAN, R
    BITTLE, JB
    KITABCHI, AE
    DIABETES, 1986, 35 : A119 - A119
  • [2] MICROANGIOPATHIES IN TYPE-I AND TYPE-II DIABETES-MELLITUS
    SALTYKOV, BB
    VELIKOV, VK
    SHUBINA, OI
    ZELENCHUK, NM
    SOVETSKAYA MEDITSINA, 1989, (10): : 77 - &
  • [3] IMMUNOCYTOCHEMICAL MORPHOMETRICS IN TYPE-I AND TYPE-II DIABETES-MELLITUS
    KLOPPEL, G
    DRENCK, CR
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1983, 108 (05) : 188 - 189
  • [4] CORRELATES OF HYPOGLYCEMIC FEAR IN TYPE-I AND TYPE-II DIABETES-MELLITUS
    POLONSKY, WH
    DAVIS, CL
    JACOBSON, AM
    ANDERSON, BJ
    HEALTH PSYCHOLOGY, 1992, 11 (03) : 199 - 202
  • [6] THE INFLUENCE OF TYPE-I AND TYPE-II DIABETES-MELLITUS ON ANTIPYRINE DISPOSITION
    MATZKE, GR
    FRYE, RF
    CARSON, SW
    MILLIKIN, SP
    LYON, JA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 134 - 134
  • [7] CORNEAL ENDOTHELIAL CHANGES IN TYPE-I AND TYPE-II DIABETES-MELLITUS
    SCHULTZ, RO
    MATSUDA, M
    YEE, RW
    EDELHAUSER, HF
    SCHULTZ, KJ
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1984, 98 (04) : 401 - 410
  • [8] GLYCEMIC CONTROL AND LIPOPROTEIN PROFILE IN TYPE-I DIABETES-MELLITUS
    PASCUAL, LG
    MANTECA, JM
    ALFONSO, GO
    CASTRO, PC
    BARREDA, FC
    CANONGE, RS
    MEDICINA CLINICA, 1991, 97 (17): : 645 - 649
  • [9] SIMILAR RISKS OF NEPHROPATHY IN PATIENTS WITH TYPE-I OR TYPE-II DIABETES-MELLITUS
    HASSLACHER, C
    RITZ, E
    WAHL, P
    MICHAEL, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1989, 4 (10) : 859 - 863
  • [10] DIFFERENTIAL EFFECT OF TYPE-I AND TYPE-II DIABETES-MELLITUS ON ANTIPYRINE ELIMINATION
    ADITHAN, C
    DANDA, D
    SHASHINDRAN, CH
    BAPNA, JS
    SWAMINATHAN, RP
    CHANDRASEKAR, S
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1989, 11 (12): : 755 - 758